Advertisement
A vs KRMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and KRMD is a StrongBuy.
A's RSI Oscillator peaks and leaves overbought zone
The 10-day RSI Oscillator for A moved out of overbought territory on October 16, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 instances where the indicator moved out of the overbought zone. In 21 of the 28 cases the stock moved lower in the days that followed. This puts the odds of a move down at 75%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 69 cases where A's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.
The Moving Average Convergence Divergence Histogram (MACD) for A turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 30 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where A declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
A broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on A as a result. In 54 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
Following a +3.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where A advanced for three days, in 187 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 137 of 209 cases where A Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 14 (best 1 - 100 worst), indicating outstanding price growth. A’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.718) is normal, around the industry mean (65.986). P/E Ratio (34.472) is within average values for comparable stocks, (3.066). Projected Growth (PEG Ratio) (1.447) is also within normal values, averaging (3.473). Dividend Yield (0.006) settles around the average of (0.002) among similar stocks. P/S Ratio (5.910) is also within normal values, averaging (9.775).
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. A’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
KRMD's Stochastic Oscillator slumps oversold zone
The Stochastic Oscillator for KRMD moved into oversold territory on November 03, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where KRMD's RSI Oscillator exited the oversold zone, 15 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on KRMD as a result. In 88 of 111 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for KRMD just turned positive on October 12, 2026. Looking at past instances where KRMD's MACD turned positive, the stock continued to rise in 39 of 48 cases over the following month. The odds of a continued upward trend are 81%.
Following a +3.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where KRMD advanced for three days, in 178 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 144 of 167 cases where KRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
Bearish Trend Analysis
KRMD moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
KRMD broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.929) is normal, around the industry mean (4.946). KRMD has a moderately low P/E Ratio (-77.500) as compared to the industry average of (38.797). Projected Growth (PEG Ratio) (1.770) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.292) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. KRMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 93 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KRMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
A | KRMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 79 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | 9 Undervalued | |
PROFIT vs RISK RATING 1..100 | 70 | 93 | |
SMR RATING 1..100 | 45 | 94 | |
PRICE GROWTH RATING 1..100 | 14 | 63 | |
P/E GROWTH RATING 1..100 | 47 | 21 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KRMD's Valuation (9) in the null industry is in the same range as A (24) in the Biotechnology industry. This means that KRMD’s stock grew similarly to A’s over the last 12 months.
A's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as KRMD (93) in the null industry. This means that A’s stock grew similarly to KRMD’s over the last 12 months.
A's SMR Rating (45) in the Biotechnology industry is somewhat better than the same rating for KRMD (94) in the null industry. This means that A’s stock grew somewhat faster than KRMD’s over the last 12 months.
A's Price Growth Rating (14) in the Biotechnology industry is somewhat better than the same rating for KRMD (63) in the null industry. This means that A’s stock grew somewhat faster than KRMD’s over the last 12 months.
KRMD's P/E Growth Rating (21) in the null industry is in the same range as A (47) in the Biotechnology industry. This means that KRMD’s stock grew similarly to A’s over the last 12 months.
| A | KRMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 3 days ago 83% |
| Stochastic ODDS (%) | 1 day ago 67% | 1 day ago 88% |
| Momentum ODDS (%) | 1 day ago 63% | 1 day ago 79% |
| MACD ODDS (%) | 1 day ago 68% | 1 day ago 81% |
| TrendWeek ODDS (%) | 1 day ago 62% | 1 day ago 83% |
| TrendMonth ODDS (%) | 1 day ago 63% | 1 day ago 84% |
| Advances ODDS (%) | 8 days ago 62% | 1 day ago 78% |
| Declines ODDS (%) | 3 days ago 63% | 20 days ago 81% |
| BollingerBands ODDS (%) | 1 day ago 71% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 66% | 1 day ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
A’s FA Score shows that 2 FA rating(s) are green while KRMD’s FA Score has 2 green FA rating(s).
- A’s FA Score: 2 green, 3 red.
- KRMD’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
A’s TA Score shows that 3 TA indicator(s) are bullish while KRMD’s TA Score has 6 bullish TA indicator(s).
- A’s TA Score: 3 bullish, 5 bearish.
- KRMD’s TA Score: 6 bullish, 3 bearish.
Price Growth
A (@Medical Specialties) experienced а -1.14% price change this week, while KRMD (@Pharmaceuticals: Other) price change was -2.21% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -2.30%. For the same industry, the average monthly price growth was -5.24%, and the average quarterly price growth was +42.12%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.70%. For the same industry, the average monthly price growth was -1.70%, and the average quarterly price growth was +10.08%.
Reported Earning Dates
A is expected to report earnings on Nov 23, 2026.
KRMD is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Medical Specialties (-2.30% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Pharmaceuticals: Other (-0.70% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
A and
Correlation & Price change
A.I.dvisor indicates that over the last year, A has been closely correlated with TMO. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then TMO could also see price increases.
KRMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, KRMD has been loosely correlated with QDEL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KRMD jumps, then QDEL could also see price increases.
| Ticker / NAME | Correlation To KRMD | 1D Price Change % | ||
|---|---|---|---|---|
| KRMD | 100% | +1.64% | ||
| QDEL - KRMD | 40% Loosely correlated | +0.43% | ||
| A - KRMD | 40% Loosely correlated | +2.02% | ||
| CLPT - KRMD | 39% Loosely correlated | -2.41% | ||
| BIO - KRMD | 38% Loosely correlated | +2.39% | ||
| NVST - KRMD | 35% Loosely correlated | +0.24% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DDTO | 23.59 | 0.07 | +0.32% |
| Innovator Equity Dual Directional 10 Buffer ETF - October (DDTO) | |||
| TQQY | 11.38 | 0.02 | +0.14% |
| GraniteShares YieldBOOST QQQ ETF (TQQY) | |||
| CGIC | 34.83 | -0.09 | -0.26% |
| Capital Group International Core Equity ETF (CGIC) | |||
| WEA | 9.72 | -0.07 | -0.72% |
| Western Asset Premier | |||
| SETM | 23.99 | -0.39 | -1.60% |
| Sprott Critical Materials ETF (SETM) | |||